Maccura Biotechnology Co.Ltd financials at a glance

+ Portfolio

The revenue of Maccura Biotechnology Co.Ltd is reported as 2.89577 billion Yuan Renminbi in the fiscal year 2023. The earnings were 0.78 Yuan Renminbi per share in 2023, which was 52.94 higher than 2016. And about 0.02361 billion Yuan Renminbi are reported as free cash flow in the financials of Maccura Biotechnology Co.Ltd 2023. Dividends of 0.16 Yuan Renminbi per share were paid to shareholders of Maccura Biotechnology Co.Ltd stock SZSE:300463 in fiscal 2023.

¥2.90B

Revenue

¥0.78

Earnings Per Share

55.27%

Gross Margin %

¥357.00M

Free Cash Flow

Revenue

2,895.77

Earnings Per Share

0.78

Gross Margin %

55.27

Free Cash Flow

357.00

Financials

Year	Year	TTM	2023	2016
Rev.	Revenue	N/A	¥2.90B	¥1.49B
GM %	Gross Margin %	54.03%	55.27%	53.90%
OM	Operating Margin	16.04%	15.59%	25.33%
EPS	Earnings Per Share	¥0.61	¥0.78	¥0.51
Div.	Dividends	N/A	¥0.16	¥0.11
PR %	Payout Ratio %	0	20.51%	21.57%
Sha.	Shares	N/AM	597.4M	558M
OCF	Operating Cash Flow	N/A	¥901.51M	¥49.32M
FCF	Free Cash Flow	N/A	¥357.00M	¥-,339.43M
FCFS	Free Cash Flow Per Share	¥-0.29	¥0.04	¥-0.61

Maccura Biotechnology Co.Ltd financials at a glance

Financials

Discover